
Christopher J McDougle MD
Child & Adolescent Psychiatry
Director of the Lurie Center for Autism Massachusetts General Hospital Harvard Medical School
Join to View Full Profile
Lurie Center for AutismOne Maguire RoadLexington, MA 02421
Phone+1 781-860-1700
Dr. McDougle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Yale-New Haven Medical CenterFellowship, Child and Adolescent Psychiatry, 1992 - 1995
- Yale-New Haven Medical CenterResidency, Psychiatry, 1986 - 1990
- Indiana University School of MedicineClass of 1986
Certifications & Licensure
- MA State Medical License 2011 - 2026
- IN State Medical License 1997 - 2013
- CT State Medical License 1988 - 1998
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2005-2014
- Boston Magazine Castle Connolly, 2012-2013
- Indianapolis Monthly Castle Connolly, 2007, 2009-2010
Clinical Trials
- Treatment of Autism in Children and Adolescents Start of enrollment: 1997 Oct 01
- Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism Start of enrollment: 2005 Sep 01
- A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome Start of enrollment: 2007 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Memantine to Treat Social Impairment in Youths With Autism Spectrum Disorder: A Randomized Clinical Trial.Gagan Joshi, Atilla Gönenc, Maura DiSalvo, Stephen V Faraone, Tolga Atilla Ceranoglu
JAMA Network Open. 2025-10-01 - Psychopharmacology Clinical Trial Recruitment Challenges in Neurogenetic Syndromes: Lessons from an Open-Label Trial of Fluoxetine in Down Syndrome.Kimaya R Gracias, Laura Sarnie, Michelle Palumbo, Caitlin Ravichandran, Christopher J McDougle
Journal of Child and Adolescent Psychopharmacology. 2025-09-22 - Preconception, prenatal and early childhood exposure to green space and risk of neurodevelopmental delays: a national cohort study among Medicaid enrollees.Hayon Michelle Choi, Krista F Huybrechts, Sonia Hernandez-Diaz, Xinye Qiu, Michael Leung
Environment International. 2025-08-01
Press Mentions
- Autism and Depression: Connections Between Autism, Mental Health, Emotions, and Other Co-Relating ConditionsMay 28th, 2019
- Why We Need a Better Awareness of How Autism Spectrum Disorder Differs in WomenApril 23rd, 2019
- Allergies More Common in Kids with AutismJune 7th, 2018
- Join now to see all
Grant Support
- 1/4-Rupp Autism Network: Guanfacine For The Treatment Of Hyperactivity In PDDNational Institute Of Mental Health2011
- Targeted Pharmacologic Interventions For AutismNational Institute Of Mental Health2010–2011
- 1/4-Rupp Autism Network: Guanfacine For The Treatment Of Hyperactivity In PDDNational Institute Of Mental Health2010–2011
- Novel Pharmacological Strategies In AutismNational Institute Of Mental Health2005–2009
- Novel Pharmacological Strategies In AutismNational Center For Research Resources2006–2008
- Aripiprazole In Children And Adolescents With Autistic DisorderNational Center For Research Resources2006–2008
- Risperidone And Behavior Therapy In Children And Adolescents With Pervasive DNational Center For Research Resources2005–2008
- Rupp-PiNational Institute Of Mental Health2002–2006
- Rg1068 (Synthetic Human Secretin) In Children With AutismNational Center For Research Resources2004–2005
- Methylphenidate In The RX Of Hyperactivity &Impulsiveness In Children W/PddNational Center For Research Resources2004
- Research Units On Pediatric Psychopharmacology--Autism-278970001National Institute Of Mental Health2003
- Research Units On Pediatric Psychopharmacology--AutismNational Institute Of Mental Health1997–2000
- Fluvoxamine Treatment Of Children With Autistic DisorderNational Center For Research Resources1996–1999
- Pharmacological Approaches To OCD TreatmentNational Institute Of Mental Health1996–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: